Covance CEO defends company’s earnings report from Q1
A few clinical trial cancellations seem to be the cause behind Covance’s weaker-than-expected growth in the last quarter, Joe Herring, chairman and CEO of Covance, said.
Archives for May 12, 2014
Pfizer-AZ merger prospects: Where will the job cuts come from?
Atop the list of concerns among political onlookers in what is shaping up to be a fierce attempt by Pfizer to acquire AstraZeneca: Jobs -- where will they be slashed and how many will lose out?
Dispatches from the Biological Production Forum
Valeant puts head in the Cloud to manage over 800 CMOs
Managing over 800 CMOs could lead to quality and compliance nightmares but Valeant says it has come up with a unique cloud-based strategy.
Drug delivery via wearable sensor in near future
A paper-thin, wearable electronic device that monitors a patient’s health status and delivers therapy as required has moved a step closer to reality.
Chinese R&D and manufacturing site part of WuXi’s 14% growth plan
WuXi PharmaTech has announced its manufacturing business, Syn-The-All (STA) Pharmaceuticals Co., Ltd., has broken ground on an R&D and manufacturing site in China.
Brazilian court charges Lilly $450m for hazardous chemicals at manufacturing facility
A Brazilian Court in Sao Paulo has ordered Eli Lilly pay about $450m for exposing former employees of its subsidiary to hazardous substances in a manufacturing facility operated between 1977 and 2003.
US FDA unveils long-awaited biosimilar guidance
The FDA has finally released its biosimilar draft guidance for industry, which details how it will evaluate comparative analytical characterization of the biosimilar in relation to the reference product.
Quintiles pushes into EHR services with Encore purchase
CRO Quintiles on Monday announced that it has signed an agreement to acquire Encore Health Resources, which offers health-information analytics and electronic health record (EHR) services.
Update
PRA adds large molecule bioanalytical capabilities to Kansas lab
CRO PRA announced Tuesday that it will add large molecule bioanalysis services in its Lenexa, Kansas, laboratory.